A TIMI STEMI score of 0 corresponds to an estimated 30-day all-cause mortality of 0.8% based on the InTIME II trial cohort.
Low-risk patients still benefit from timely reperfusion therapy. Continue standard STEMI protocol management.
The TIMI STEMI score was derived from patients receiving fibrinolytic therapy. For primary PCI outcomes, the PAMI risk score or GRACE score may offer additional context.
Next stepProceed with standard STEMI reperfusion pathway and continuous cardiac monitoring.